Who ever thought #hookworms might have an benefit for #MetabolicHealth? A small RCT opens the door to the possibility they might prevent #T2D in persons with insulin resistance.
https://conscienhealth.org/2023/08/the-effect-of-hookworms-on-metabolic-health/
#hookworms #metabolichealth #T2D
@bedast It really bugs me that these meds, which so many depend upon, are being touted off-label for weight loss ... and that shortages are resulting.
I'm fortunate that my #T2D is under control with diet and exercise at this time, but I know that won't always be the case. I am sure Metformin is in my future, if not one of the other meds as well.
I hope you are able to find some resolution to this crucial availability problem soon.
I think it's also important to note that a lot of issues that we didn't think were related to the gut we are now finding directly connected to the microbiome and that these issues likely extend much further than conditions like #IBS or #SIBO.
Metabolic conditions ie #T2D, #inflmmation, #immune function, and #inflammation are all included in this.
#ibs #SIBO #T2D #inflmmation #immune #inflammation
RT IDFEurope / Diabetes
👉Can we prevent 1 million people living with #T2D dying prematurely in Europe each year? Why are we not acting? Why is science not translated into practice?
⬇️Learn more about our call to action: https://www.euractiv.com/section/health-consumers/opinion/type-2-diabetes-a-preventable-catastrophe/
@kamleshkhunti
@TBattelino
@Franc_Bogovic
1/2 https://t.co/mRJ80FZpDW
🐦🔗: https://n.respublicae.eu/IDFEuropeBXL/status/1669008327483748360
RT @IDFEuropeBXL: Opening the panel discussion, Erik Werson, #diabetes advocate living with #T2D discussed the difficult transition from initial diagnosis and treatment to self diabetes management. https://t.co/F6Xlz5CEAP
🐦🔗: https://n.respublicae.eu/Franc_Bogovic/status/1666161125908533249
RT @SweetenersAndU: 🔴Type 2 #Diabetes: a preventable catastrophe?
"It’s not only about death but also about losing quality of life"
"The most important thing is to give access to early detection of #T2D"
@kamleshkhunti @EUDiabetesForum @Prof_K_Barnard @IDFEuropeBXL @Franc_Bogovic @EURACTIV
https://t.co/tA5ONtaik7
🐦🔗: https://n.respublicae.eu/Franc_Bogovic/status/1666052661613932547
RT @IDFEuropeBXL: 📅On June 6, MEP @Franc_Bogovic, member of @MEPsDiab, will join our event "#T2D: a preventable catastrophe" to highlight the urgent need for increased policy action to reduce the burden of T2D on people and health systems.
➡More about the event: https://events.euractiv.com/event/info/media-partnership-type-2-diabetes-a-preventable-catastrophe https://t.co/KtXb5lNPTG
🐦🔗: https://n.respublicae.eu/Franc_Bogovic/status/1664597229439533056
RT @SABOURETCardio
Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of #T2D #RCT https://www.nature.com/articles/s41591-023-02287-7
#cardiomastodon @bmj_latest
The right dietary & lifestyle would minimised the mortality risks in diabetes individuals. In this #cohortstudy of 15 486 patients in the course of 18.5 years of followup .Higher intake of SSBs was associated with higher all cause mortality & #CVD incidence & mortality, whereas intakes of coffee, tea, plain water, and low fat milk were inversely associated with all cause mortality incase of #T2D individual
https://www.bmj.com/content/381/bmj-2022-073406
#cardiomastodon #cohortstudy #cvd #T2D
In late 2021 I was diagnosed with type-2 diabetes. By March 2022 I was out of the diabetic range and in March 2023 it was confirmed that my T2D is in remission. At no point did I use any medication.
I've started a Substack to post about what I did and what I'm doing now. It is, and will remain, free. Link below
RT @ckd_ce
4) How do we know which pts with #T2D are at risk for #CKD? @AmDiabetesAssn & @goKDIGO recently released consensus screening guidelines. Unfortunately, <50% of those with #T2D are screened for albuminuria annually.
🔓https://pubmed.ncbi.nlm.nih.gov/36189689/
RT @ckd_ce
1) Welcome to our #accredited #tweetorial on individualized strategies to risk-stratify, manage, & educate pts with advancing #CKD in the setting of #T2D. I am James Novak MD PhD @JamesNovakNeph from @HenryFordHealth. @HFHNephFellow @HFHIntMedRes #Nephtwitter #Medtwitter #FOAMed
#accredited #tweetorial #CKD #T2D #NephTwitter #medtwitter #FOAMed
RT @SABOURETCardio
Efficacy and Safety of #Alirocumab 300 mg Every 4 Weeks in Individuals With #T2D. Efficient and well tolerated 1/month. Associated with fixed #LLT combinations HI #statins and #ezetimibe #lipids https://academic.oup.com/jcem/article-abstract/104/11/5253/5510497
#alirocumab #T2D #llt #statins #ezetimibe #lipids
RT @SABOURETCardio
#PCSK9i This #MA confirms that #PCSK9i work in #T2D patients "the higher is the baseline risk, the higher are the benefits" (as usual) #lipids https://academic.oup.com/ehjcvp/advance-article-abstract/doi/10.1093/ehjcvp/pvad019/7087275?redirectedFrom=fulltext
I’m grateful to have incrementally learned preventive measures against the ulcers, and relieved at the spontaneous/concomitant cessation of the other symptoms.
I’m grateful that the diagnoses of #T2D and chronic idiopathic axonal polyneuropathy were not delayed longer than 4 decades, and were made before precipitation by some crippling or (more) life-threatening catastrophe.
4/5
RT @SABOURETCardio
"To every complex situation, there is a solution that is clear, simple and...wrong" #OpenAccess #T2D thanks to @marcobernardi @LuigiSpadafora @MattiaGalli10 @gbiondizoccai and @maciejbanach https://www.archivesofmedicalscience.com/Should-SGLT2-inhibitors-be-prescribed-in-all-diabetic-type-2-patients-,160006,0,2.html
I tend not to respond to you bedast, you tend to leave out significant relevant points (what specific basal insulin do you use). I do, however, find it interesting that you have been prescribed Mounjaro without ever having seen an endo. I've been diabetic for at least 15 years, and have seen an endo retire, and her protege take me on as his patient - for a total of about 15 years. So, you had a GP prescribe insulin??? That is also unusual.